BR112015002584A8 - uso de lipossoma e composição farmacêutica - Google Patents
uso de lipossoma e composição farmacêutica Download PDFInfo
- Publication number
- BR112015002584A8 BR112015002584A8 BR112015002584A BR112015002584A BR112015002584A8 BR 112015002584 A8 BR112015002584 A8 BR 112015002584A8 BR 112015002584 A BR112015002584 A BR 112015002584A BR 112015002584 A BR112015002584 A BR 112015002584A BR 112015002584 A8 BR112015002584 A8 BR 112015002584A8
- Authority
- BR
- Brazil
- Prior art keywords
- liposome
- pharmaceutical composition
- liposomes
- relates
- present
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 7
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 206010020575 Hyperammonaemia Diseases 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002917 insecticide Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000003200 peritoneal cavity Anatomy 0.000 abstract 1
- 239000000575 pesticide Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
uso de lipossoma e composição farmacêutica. a presente invenção se refere a uma composição de lipossoma para ser usada na diálise peritonial de pacientes que estejam sofrendo de toxicopatias endógenas ou exógenas, nas quais o ph dentro dos lipossomas é diferente do ph na cavidade peritonial e em que o ph dentro do lipossoma resulta em uma toxina carregada encapsulada no lipossoma. a invenção também se refere a uma composição farmacêutica que compreende os referidos lipossomas. um outro aspecto da presente invenção se refere a um método para o tratamento de paciente que estejam sofrendo de toxicopatias endógenas ou exógenas, selecionadas de preferência a partir de fármaco, metabólito, pesticida, inseticida, toxina e toxicopatias de guerra química, preferencialmente hiperamonemia, que compreende as etapas da administração de lipossomas da invenção em uma quantidade terapeuticamente efetiva no interior do espaço peritonial de um paciente que esteja necessitando da mesma. além dos seres humanos, a presente invenção é especificamente adequada aos aspectos veterinários.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12005796.3 | 2012-08-09 | ||
| EP12005796.3A EP2695606A1 (en) | 2012-08-09 | 2012-08-09 | Liposome composition for peritoneal dialysis |
| PCT/EP2013/002352 WO2014023421A1 (en) | 2012-08-09 | 2013-08-06 | Liposome composition for use in peritoneal dialysis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112015002584A2 BR112015002584A2 (pt) | 2017-07-04 |
| BR112015002584A8 true BR112015002584A8 (pt) | 2019-07-30 |
| BR112015002584B1 BR112015002584B1 (pt) | 2023-03-07 |
Family
ID=47022433
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR122019024753-6A BR122019024753B1 (pt) | 2012-08-09 | 2013-08-06 | Uso de lipossoma |
| BR112015002584-6A BR112015002584B1 (pt) | 2012-08-09 | 2013-08-06 | Uso de lipossoma e composição farmacêutica |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR122019024753-6A BR122019024753B1 (pt) | 2012-08-09 | 2013-08-06 | Uso de lipossoma |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10596114B2 (pt) |
| EP (3) | EP2695606A1 (pt) |
| JP (1) | JP5956075B2 (pt) |
| KR (2) | KR101966308B1 (pt) |
| CN (2) | CN110269841A (pt) |
| AU (1) | AU2013301901B9 (pt) |
| BR (2) | BR122019024753B1 (pt) |
| CA (1) | CA2894784C (pt) |
| DK (1) | DK2882421T3 (pt) |
| ES (1) | ES2922278T3 (pt) |
| HK (1) | HK1209059A1 (pt) |
| MX (1) | MX362882B (pt) |
| PT (1) | PT2882421T (pt) |
| RU (1) | RU2609860C2 (pt) |
| WO (1) | WO2014023421A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2695606A1 (en) * | 2012-08-09 | 2014-02-12 | ETH Zürich | Liposome composition for peritoneal dialysis |
| WO2016048242A1 (en) * | 2014-09-24 | 2016-03-31 | Nanyang Technological University | Sustained timolol maleate delivery from liposomes for glaucoma therapy and ocular hypertension |
| US10710044B2 (en) | 2015-04-02 | 2020-07-14 | Nanyang Technological University | Tubular and vesicular architectures formed from polymer-lipid blends and method for forming the same |
| JP6715265B2 (ja) * | 2015-05-04 | 2020-07-01 | フェルザンティス アーゲーＶｅｒｓａｎｔｉｓ Ａｇ | 膜内外ｐＨ勾配ベシクルを調製する方法 |
| EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
| US20190127736A1 (en) * | 2016-04-29 | 2019-05-02 | Aptamir Therapeutics, Inc. | Inhibition of mir-22 mirna by apt-110 |
| CN106220562B (zh) * | 2016-07-29 | 2019-10-01 | 上海璃道医药科技有限公司 | 两种喹啉环类药物的新用途 |
| EP3500311B1 (en) | 2016-08-16 | 2020-05-27 | ETH Zurich | Transmembrane ph-gradient polymersomes and their use in the scavenging of ammonia and its methylated analogs |
| EP3668927B1 (en) * | 2017-09-12 | 2024-03-20 | ETH Zurich | Transmembrane ph-gradient polymersomes for the quantification of ammonia in body fluids |
| KR20190085734A (ko) | 2018-01-11 | 2019-07-19 | 이광영 | 말뚝의 결합장치 |
| US20210015844A1 (en) * | 2018-03-14 | 2021-01-21 | Beacon Medcare (Hk) Limited | Composition for purification of biofluids |
| CN111939126A (zh) * | 2019-05-15 | 2020-11-17 | 上海交通大学医学院附属第九人民医院 | 一种阳离子脂质体、包含所述脂质体的分散液及它们的制备方法和用途 |
| CN109966277B (zh) * | 2019-05-23 | 2021-04-30 | 济宁医学院附属医院 | 一种治疗难治性癫痫的药物组合物及其应用 |
| CN112294763A (zh) * | 2019-07-30 | 2021-02-02 | 上海交通大学医学院附属第九人民医院 | 一种腹膜透析用脂质体分散液及其制备方法和用途 |
| KR20210128169A (ko) | 2020-04-16 | 2021-10-26 | 이광영 | 파일 결합 장치 |
| US20240000754A1 (en) | 2020-11-17 | 2024-01-04 | Genfit | Methods of treatment of liver failure |
| CN112933045B (zh) * | 2021-04-09 | 2022-04-12 | 贵州医科大学 | 共载双氢青蒿素/磷酸氯喹双敏感纳米制剂及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE446063B (sv) | 1978-02-01 | 1986-08-11 | Exxon Research Engineering Co | Vetskemembrankapsel som er motstandskrafitg mot koalescens och forfarande for framstellning av vetskemembrankapslar |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| US20040208922A1 (en) * | 1995-06-07 | 2004-10-21 | The Regents Of The University Of California | Method for loading lipid like vesicles with drugs or other chemicals |
| US5972905A (en) * | 1995-06-14 | 1999-10-26 | Institute Of Immunology Co., Ltd. | Use of oligosaccharides for the treatment of pruritus cutaneus associated with renal failure |
| EP0863748A4 (en) * | 1995-10-11 | 1999-11-03 | Kevin Jon William | LIPOSOMAL COMPOSITIONS AND METHODS OF USE |
| CN1160585A (zh) * | 1995-12-22 | 1997-10-01 | 贝尔科公开有限公司 | 除去脂溶性靶分子的方法，纯化血液的透析装置及洗涤溶液 |
| DE10117043A1 (de) * | 2001-04-05 | 2002-11-07 | Gerhard Puetz | Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen |
| US20030129224A1 (en) * | 2001-11-13 | 2003-07-10 | Paul Tardi | Lipid carrier compositions and methods for improved drug retention |
| US20090306625A1 (en) * | 2007-03-09 | 2009-12-10 | Angiodynamics, Inc. | Treatment systems and methods for renal-related diseases |
| JP5450612B2 (ja) * | 2008-06-18 | 2014-03-26 | ライフボンド リミテッド | 改良された架橋組成物 |
| EP2695606A1 (en) * | 2012-08-09 | 2014-02-12 | ETH Zürich | Liposome composition for peritoneal dialysis |
-
2012
- 2012-08-09 EP EP12005796.3A patent/EP2695606A1/en not_active Withdrawn
-
2013
- 2013-08-06 RU RU2014153193A patent/RU2609860C2/ru active
- 2013-08-06 DK DK13745798.2T patent/DK2882421T3/da active
- 2013-08-06 CN CN201910232676.6A patent/CN110269841A/zh active Pending
- 2013-08-06 US US14/420,654 patent/US10596114B2/en active Active
- 2013-08-06 CN CN201380042294.8A patent/CN104519873A/zh active Pending
- 2013-08-06 KR KR1020157001870A patent/KR101966308B1/ko active IP Right Grant
- 2013-08-06 KR KR1020177022844A patent/KR101993775B1/ko active IP Right Grant
- 2013-08-06 AU AU2013301901A patent/AU2013301901B9/en active Active
- 2013-08-06 BR BR122019024753-6A patent/BR122019024753B1/pt active IP Right Grant
- 2013-08-06 JP JP2015525780A patent/JP5956075B2/ja active Active
- 2013-08-06 PT PT137457982T patent/PT2882421T/pt unknown
- 2013-08-06 MX MX2015000740A patent/MX362882B/es active IP Right Grant
- 2013-08-06 CA CA2894784A patent/CA2894784C/en active Active
- 2013-08-06 EP EP13745798.2A patent/EP2882421B1/en active Active
- 2013-08-06 EP EP22172208.5A patent/EP4062905A1/en active Pending
- 2013-08-06 WO PCT/EP2013/002352 patent/WO2014023421A1/en active Application Filing
- 2013-08-06 ES ES13745798T patent/ES2922278T3/es active Active
- 2013-08-06 BR BR112015002584-6A patent/BR112015002584B1/pt active IP Right Grant
-
2015
- 2015-10-12 HK HK15109906.7A patent/HK1209059A1/xx unknown
-
2018
- 2018-10-19 US US16/165,202 patent/US20190105270A1/en not_active Abandoned
-
2020
- 2020-09-11 US US17/018,438 patent/US11896712B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015002584A8 (pt) | uso de lipossoma e composição farmacêutica | |
| CY1119616T1 (el) | Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα | |
| BR112013026308A2 (pt) | Compostos de benzeno substituídos | |
| CR20120638A (es) | Métodos de terapia combinada para tratar enfermedades proliferativas | |
| BR112015008487A2 (pt) | compostos de benzeno substituído | |
| PH12015500407B1 (en) | Methods of treating hypertriglyceridemia | |
| BR112019003557A2 (pt) | derivados de oxopicolinamida, método de preparação dos mesmos e uso farmacêutico dos mesmos | |
| BR112013018920A2 (pt) | composições de nanopartículas, formulações destas e seus usos | |
| BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| BR112015000776A2 (pt) | Agentes de ligação à rspo3 e usos dos mesmos | |
| BR112014018953A8 (pt) | Derivados de lupano triterpenoide e uso farmacêutico dos mesmos | |
| BR112014028315A2 (pt) | mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit | |
| BRPI1009842B8 (pt) | uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas | |
| BR112015022650A2 (pt) | inibidores de cinase induzível por sal macrocíclico | |
| BR112015023481A2 (pt) | composição de lipossoma de liberação controlada de fármaco | |
| BR112014020271A8 (pt) | Composição farmacêutica e métodos para diminuir a frequência de micção em paciente | |
| HRP20161147T1 (hr) | Farmaceutski sastav i postupak njegove proizvodnje | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BR112018072988A2 (pt) | irinotecano lipossômico para uso no tratamento de câncer de pulmão de pequenas célula | |
| BR112015000616A2 (pt) | tratamento da esclerose múltipla com combinação de laquinimode e fampridina | |
| UA111147C2 (uk) | Способи та композиції для лікування або профілактики зовнішнього отиту | |
| BR112016000092A2 (pt) | nanopartículas lipídicas para a cicatrização de feridas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/08/2013, OBSERVADAS AS CONDICOES LEGAIS |